NSC Healthcare Pvt. Ltd. is a registered company under Indian company act 1956 and its all products has GMPO Certificate and basically a pharmaceutical company deal with neuro-psychiatry products as a main strength of the Company and introduce in the mark in 17th May 2016 & with its positive growth the company has reached to almost 48 products and with a growth rate of approx. 352.77% in very third year of its launching.
Understanding the present world economic situation company understand the demand and need of market as the consumer are day by day move towards digital platform. And also understand the market demand and business opportunity in all the chronic diseases like cancer / Kidney/ Heart-Problem and accordingly plan to bring some new molecule first time in India to capture the market share in scientific way.
As we plan to enter into the most important and chronic segment in Human Diagnosis & AI Based Robotic Technology. So, keeping that in mind we are planning and invest to create the entire eco-system Where we are bring the Best medical facility and world class treatment (teaching facility), AI based technology in India via our Hospital and Medical & Engineering College and R&D and also provide quality medicine in affordable price we are plan to open our World class R&D facility & Factory with production facility.
So, keeping the opportunity in mind the company is planning to invest 2000 Cr in next 5 years in 4 different segments like --1) Marketing 2) Medical & Engineering College & AI Medical Robots Manufacturing 3) Healthcare & Food Product Manufacturing 4) R&D in Medical fusion with AI Technology through this project “SIDDHI” in NSC HEALTHCARE to create proper ECO-SYSTEM & digital platform and to promote our company and reach to Globule market. As the globalization in India has already affected all the small and mediocre Company. So, it important to make the Company Size Gobble to fight with all the Indian and Foreign big bull Companies and which will also give us opportunity to collaborate with the Foreign Player.